Spirometer Market to Be Worth $1.80 Billion by 2031-Exclusive Report by Meticulous Research®

According to a new market research report titled 'Spirometer Market Size, Share, Forecast, & Trends Analysis by Product (Spirometer [Incentive, Professional, Wireless, Handheld, Stationary, USB]) Technology (Volume, Peak Flow) Application (COPD, Asthma, Cystic fibrosis) End User - Global Forecast to 2031,' published by Meticulous Research®, the spirometer market is projected to reach $1.80 billion by 2031, at a CAGR of 9.2% during the forecast period.

A spirometer is a device that measures the volume of air that can be inhaled and exhaled by the lungs. Various types of spirometers are available, including incentive spirometers, professional spirometers, table-top or stationary spirometers, digital spirometers, and PC-based spirometers. These devices are utilized in the diagnosis of a range of respiratory conditions, including Chronic Obstructive Pulmonary Disease (COPD), asthma, cystic fibrosis, and other respiratory diseases.

The growth of this market is driven by the rising incidence of respiratory diseases, technological advancements in spirometers, increasing awareness programs regarding respiratory diseases, and the growing preference for home healthcare. However, the high cost of spirometers and a shortage of skilled professionals may restrain the market's growth.

Additionally, partnerships & collaborations between market players aimed at advancing spirometers and the rising demand from emerging economies are expected to create market growth opportunities. However, the availability of alternative technologies is a significant challenge impeding the market's growth.

Download Free PDF Sample Copy of the Report : https://www.meticulousresearch.com/download-sample-report/cp_id=5924
Growing Preference for Home Healthcare Driving Market Growth

The increase in the aging population and the prevalence of chronic diseases are driving the demand for home healthcare medical devices and services, including spirometers. According to the World Health Organization (WHO), the global share of the senior population (aged 65 years and above) increased by 10% in 2022 and is projected to rise to 16% by 2050. Home healthcare devices like spirometers enable patients requiring extra care to remain in the comfort of their homes. This trend towards home care is increasingly preferred by the elderly population in need of long-term care. Additionally, patients with mobility issues also favor home healthcare services. The surge in the aging population, coupled with lifestyle-related ailments among the younger demographic and escalating healthcare costs, is driving the growth of the spirometer market.

The spirometer market is segmented based on Product (Devices, [Type {Incentive Spirometer, Professional Spirometers, Digital Peak Flow Meters, Smart Digital Spirometers, Other Spirometers}, Portability {Table-top/Stationary Spirometers, Handheld Spirometers}, Connectivity {Wireless Spirometers, USB Spirometers}], Consumables & Accessories, Software), Technology (Volume Measurement, Peak Flow Measurement), Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Cystic fibrosis, Pulmonary fibrosis, Other Applications), End User (Hospitals & Clinics, Home Care Settings, Ambulatory Care Centers), and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.

The report also includes an extensive assessment of the key growth strategies adopted by leading market players over the past three to four years. Some of the key players operating in the spirometer market are Hill-Rom Holdings, Inc. (U.S.) (a subsidiary of Baxter International Inc. (U.S.), Schiller Americas Inc. (U.S.), Vyaire Medical, Inc. (U.S.), Koninklijke Philips N.V.(Netherlands), KoKo, LLC (U.S.), Midmark Corporation (U.S.), Geratherm Medical AG (Germany), CHEST M.I., Inc. (Japan), Fukuda Sangyo Co., Ltd. (Japan), ndd Medical Technologies (U.S.), MGC Diagnostics Corporation (U.S.), COSMED srl (Italy), and SIBEL, SAU (Spain).

Request Customization : https://www.meticulousresearch.com/request-customization/cp_id=5924

Among the products covered in this report, in 2024, the devices segment is expected to account for the largest share of 65.2% of the spirometer market. This segment's large market share can be attributed to the technological advancements in spirometers, transitioning from fixed, volume-based devices to portable, flow-based devices that offer increased convenience in transportation. Additionally, the segment's growth is driven by the rising number of approvals for advanced spirometers. For instance, in January 2024, NuvoAir Inc. (U.S.) received FDA 510(k) clearance for its NuvoAir air next wireless spirometer. This spirometer allows individuals to conduct comprehensive lung function tests from the comfort of their homes, providing valuable data for continuous monitoring of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and amyotrophic lateral sclerosis (ALS).

Among the technologies covered in this report, in 2024, the peak flow measurement segment is expected to account for the larger share of the spirometer market. This segment's large market share can be attributed to the increasing applications of peak flow measurement spirometers in asthma management.

Among the applications covered in this report, in 2024, the Chronic Obstructive Pulmonary Disease (COPD) segment is expected to account for the largest share of the spirometer market. This segment's large market share can be attributed to the rising number of COPD patients and the quick and efficient diagnosis of COPD through spirometry testing.
Among the end users covered in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of 53.7% of the spirometer market. This segment's large market share can be attributed to the rising cases of respiratory conditions such as asthma, COPD, and pulmonary fibrosis, leading to a significant number of patient visits in hospitals & clinics. For instance, according to the Australian Bureau of Statistics, in 2022, 2.8 million individuals were reported to have asthma in Australia.

Based on geography, the spirometer market is segmented into North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and the Middle East & Africa. In 2024, North America is expected to account for the largest share of 41.6% of the spirometer market. North America's significant market share can be attributed to the increasing incidence of respiratory diseases such as COPD and asthma, the presence of prominent spirometer companies in the region, and the implementation of awareness programs focused on respiratory health. For instance, in November 2023, the American Lung Association launched the 'COPD for Life' program aimed at enhancing the quality of life for individuals with long-term COPD. However, the market in Asia-Pacific is projected to register the highest CAGR during the forecast period.

You can Buy Report from Here: https://www.meticulousresearch.com/Checkout/80133321

Scope of the Report:
Spirometer Market Assessment-by Product
• Devices
o Type
 Incentive Spirometers
 Professional Spirometers
 Digital Peak Flow Meters
 Smart Digital Spirometers
 Other Spirometers
o Portability
 Table-top/Stationary Spirometers
 Handheld Spirometers
o Connectivity
 Wireless Spirometers
 USB Spirometers
• Consumables & Accessories
• Software
Note: Other spirometers include windmill-type spirometers and pneumotachometers.
Spirometer Market Assessment-by Technology
• Volume Measurement
• Peak Flow Measurement
Spirometer Market Assessment-by Application
• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Cystic Fibrosis
• Pulmonary Fibrosis
• Other Applications
Note: Other applications include bronchiectasis, lung cancer, emphysema, and chronic bronchitis.
Spirometer Market Assessment-by End User
• Hospitals & Clinics
• Home Care Settings
• Ambulatory Care Centers
Spirometer Market Assessment-by Geography
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o Italy
o U.K.
o Spain
o Switzerland
o Netherlands
o Rest of Europe
• Asia-Pacific
o China
o Japan
o India
o Australia
o South Korea
o Singapore
o Rest of Asia-Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• Middle East & Africa
o UAE
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/spirometer-market-5924

CAR T-cell Therapy Market: https://www.meticulousresearch.com/product/car-t-cell-therapy-market-5508

Medical Image Management Market: https://www.meticulousresearch.com/product/medical-image-management-market-4761

Tissue Diagnostics Market: https://www.meticulousresearch.com/product/tissue-diagnostics-market-4971

Dialysis Market: https://www.meticulousresearch.com/product/dialysis-market-5137

About Us
We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.

Address
Office No-202, 203,204,205,206
2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad,
411057, India.

This release was published on openPR.